Enhanced nanoencapsulation of gentamicin, ciprofloxacin, and lysozyme in chitosan-MIL-53 metal-organic frameworks for a synergistic activity against drug-resistant <i>Salmonella</i> from poultry and human origins.

RSC Adv · 2026 · PMC13086064 · PMID 42006814

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The exceptionally low p -values ( p < 0.0001) and high R 2 values confirm that the models are highly significant and explain a great majority of the variability in the data.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Enhanced nanoencapsulation of gentamicin, ciprofloxacin, and lysozyme in chitosan-MIL-53 metal-organic frameworks for a synergistic activity against drug-resistant &lt;i&gt;Salmonella&lt;/i&gt; from poultry and human origins.

The sentences

Enhanced nanoencapsulation of gentamicin, ciprofloxacin, and lysozyme in chitosan-MIL-53 metal-organic frameworks for a synergistic activity against drug-resistant <i>Salmonella</i> from poultry and human origins.